Loncastuximab Tesirine and Epcoritamab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

Universität Münster1

Indications

Follicular Lymphoma (FL) Grade 3B1
Aggressive Diffuse Large B-cell Lymphoma1
High-grade B-cell Lymphoma (HGBL)1
Cancer1

Other1 trial

Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.